Gene: FANCC
Official Full Name: FA complementation group Cprovided by HGNC
Gene Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group C. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03971 | FANCC Knockout cell line (HeLa) | Human | FANCC | 1:3~1:6 | Negative | Online Inquiry |
KO03972 | FANCC Knockout cell line (HCT 116) | Human | FANCC | 1:2~1:4 | Negative | Online Inquiry |
KO03973 | FANCC Knockout cell line (HEK293) | Human | FANCC | 1:3~1:6 | Negative | Online Inquiry |
KO03974 | FANCC Knockout cell line (A549) | Human | FANCC | 1:3~1:4 | Negative | Online Inquiry |
FANCC Gene Knockout Cell Lines are specifically engineered cellular models that possess a targeted disruption of the FANCC gene, which plays a crucial role in the Fanconi anemia (FA) pathway. This biological product serves as a vital tool for scientists investigating the molecular mechanisms driving FA, a rare genetic disorder characterized by bone marrow failure and increased cancer susceptibility. These knockout cell lines allow for the dissection of FANCC's functions in DNA repair and maintenance, providing a clearer understanding of its role in genomic stability.
The primary function of these cell lines is to facilitate the study of cellular responses to DNA crosslinking agents and oxidative stress, conditions that are particularly relevant in the context of FA. By eliminating the FANCC gene, researchers can observe the resultant phenotypic changes, such as increased sensitivity to agents like mitomycin C, thereby elucidating the underlying mechanisms of how FANCC contributes to the repair of damaged DNA.
In research and clinical settings, FANCC Gene Knockout Cell Lines hold substantial scientific importance as they enable the investigation of potential therapeutic targets and strategies for treating FA. They are also instrumental in screening for novel compounds that can enhance DNA repair mechanisms, ultimately contributing to cancer research where FA patients exhibit a predisposition to malignancies.
One significant advantage of these cell lines is their fidelity to the human genetic background, providing a more accurate representation of disease pathology compared to traditional models. Furthermore, the precision of gene knockout technology ensures reproducibility and reliability in experimental outcomes, making them a preferred choice for researchers striving for rigorous results.
For researchers and clinicians focused on genetic disorders, cancer biology, or therapeutic development, FANCC Gene Knockout Cell Lines present an invaluable resource. Their unique ability to model specific genes' disruption allows for advanced understanding and innovative findings that could pave the way for novel interventions.
At [Your Company Name], we specialize in offering high-quality biological products designed to meet the rigorous demands of the scientific community. Our expertise in genetic engineering and commitment to excellence ensures that we provide reliable tools for breakthroughs in research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.